Therapeutic Strategies for Autoimmune Hepatitis

@article{Manns2011TherapeuticSF,
  title={Therapeutic Strategies for Autoimmune Hepatitis},
  author={M. Manns and C. Strassburg},
  journal={Digestive Diseases},
  year={2011},
  volume={29},
  pages={411 - 415}
}
  • M. Manns, C. Strassburg
  • Published 2011
  • Medicine
  • Digestive Diseases
  • Autoimmune hepatitis (AIH) is a disease of unknown etiology. However, a loss of tolerance against the patient’s own liver is regarded as the main pathogenetic mechanism. Immunosuppressive therapy prolongs survival in patients with severe AIH. Two phases of therapy have to be distinguished. In newly diagnosed AIH, induction of remission is the main goal. Here predniso(lo)ne alone or in combination with azathioprine has been shown to induce remission in the majority of patients. In the past… CONTINUE READING
    12 Citations
    Advances in the Current Treatment of Autoimmune Hepatitis
    • A. Czaja
    • Medicine
    • Digestive Diseases and Sciences
    • 2012
    • 42
    The Geoepidemiology of Autoimmune Liver Disease
    • 1
    Autoimmune hepatitis: A noninfectious killer
    • L. Ferguson
    • Medicine
    • Journal of the American Association of Nurse Practitioners
    • 2014
    • 1
    • Highly Influenced

    References

    SHOWING 1-10 OF 19 REFERENCES
    Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    • 319
    Budesonide in previously untreated autoimmune hepatitis
    • J. Wiegand, A. Schueler, +10 authors M. Manns
    • Medicine
    • Liver international : official journal of the International Association for the Study of the Liver
    • 2005
    • 90
    Autoimmune Hepatitis in Brazil: An Overview
    • 24